Oculis
potential to transform treatment of moderate to severe dry eye patients with novel anti eye drop anti a | Oculis
Company
Deck Type
Deck date
April 2024
Slide
38 of 48
Related slides by other companies
AstraZeneca
Investor Conference
January 2024
i young portfolio of novel blockbuster medicines | AstraZeneca
Bausch+Lomb
Results
May 2023
building a global dynamic dry eye disease platform dry eye total revenue for | Bausch+Lomb
DICE Therapeutics
Investor Presentation
March 2023
progression to phase in psoriasis dice severity pas | DICE Therapeutics
Adagio Therapeutics
Investor Conference
June 2023
millions of people are in urgent need of new therapeutics that provide passive immunity to covid | Adagio Therapeutics
Other recent decks by Oculis
See all presentations (7 decks)
Results
August 2023
Investor Presentation
July 2023
Investor Conference
June 2023
Results
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io